[ad_1]
NEW YORK, NY / ACCESSWIRE / September 19, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on publicly traded small- and mid-cap companies, recently released a new C-Level interview with Stemtech Corporation.
Mark had the pleasure of recently conducting the interview with Charles Arnold, CEO of Stemtech Corporation (OTCQB:STEK). Mr. Roberts diligently focused on issues that he believed would be of concern to most current and potential future shareholders. Check out the interview highlights below.
Access this interview in its entirety at https://tradersnewssource.com/stek-interview/
CHARLES ARNOLD
CEO Stemtech Corp.
Mr. Arnold’s ability to integrate marketing concepts and financial strategies plays a key role in the development of his clients’ businesses. In addition to developing startups, he has been responsible for placing more than $1 billion in public companies with up to $400 million in a single transaction. Significant mergers and acquisitions have been completed through his network of financial specialists and professionals around the world. In 1993, Mr. Arnold was one of the original investors in prepaid legal “PPD” (now Legal Shield). In 2001 he was hired by Natural Health Trends “LEXXUS”, the company grew from under $1.00 to over $40. It is traded on the US stock exchange. Mr. Arnold believes that direct sales marketing is an underserved market that deserves the attention of investors. Mr. Arnold believes that Stemtech has tremendous growth potential and sees a bright future for this company with our innovative stem cell nutrition products and the financial opportunity for our independent business partners.
Over the years, Mr. Arnold has carefully developed worldwide relationships with retail brokerage firms, investment bankers, traders, fund managers and independent investors. A wide range of its functions include public awareness and financial relations campaigns organized to bring undervalued, little-known public companies with significant growth potential to the center of equity markets around the world.
For more than 35 years, Mr. Arnold has traveled extensively as a guest speaker for many private and public affairs, including international investment conferences. Mr. Arnold’s group of investors consultants managed to participate in several profitable ventures. Mr. Arnold retired from the speaking circuit in 1998. Mr. Arnold was president and publisher of two financial publications from 1984-1998 (Personal Investing News) with a paid circulation of over 500,000 subscribers and (The Sound Money Investor ) geopolitical publication with a paid circulation of 80,000. In addition, Mr. Arnold hosted 4-6 financial conferences per year (Sound Money Investor Conferences). Since 1998, now concentrating on his core business, he remains in high demand internationally as an author and lecturer at seminars on entrepreneurship and business economics and development.
Highlights of the interview:
Trader News Source Editor Mark Roberts covers the future vision for the company, details of the LFR acquisition, the synergistic aspects of the LFR acquisition plus much more in this interview.
Access this interview in its entirety at https://tradersnewssource.com/stek-interview/
About Stemtech Corporation
Stemtech Corporation, a leading nutritional supplement company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations of its predecessor, Stemtech International, Inc., which was founded in 2005. From 2010 to 2015 .Stemtech International, Inc. , was recognized four separate times on Inc.’s list. 5000 Fastest Growing Companies. In 2018, the company underwent an extensive executive reorganization and continued operations under new management. Stemtech specializes in creating products and formulations that are patent protected in the US and select international markets. The company’s proprietary formulas support the release, circulation and migration of adult stem cells from the body’s bone marrow. The company offers its products under the following brands: RCM System, stemrelease3™, Stemflo® MigraStem, OraStem® (Oral Health Care) and D-Fuze™ (EMF blocker). Its nutritional supplements are all-natural, plant-based, and manufactured under cGMP (Current Good Manufacturing Practices) under the auspices of the Dietary Supplement Health and Education Act (DSHEA). For more information, please visit www.stemtech.com.
Investor Relations:
Frank J. Peña, 908 675-0581
[email protected]
About Trader News Source (TNS)
Traders News Source is a leading independent stock research and corporate access firm focused on finding and reporting on the next hot stocks and market sectors before a significant move. TNS is also a financial news provider focused on giving investors direct access to CEOs of promising, publicly traded companies and market experts. Our C-level interviews answer some of the tough questions that concern most current and prospective shareholders. TNS C-level interviews provide valuable insight into the operations and management direction of some of the most promising small and mid-sized publicly traded companies. To view the TNS Disclosure Statement, please visit: https://tradersnewssource.com/stek-interview/
Contact with the media
News source for marketers
Mark Roberts, Senior Editor/Interviewer [email protected]
or call Paul Lipp, President of TNS LLC at +1-810-618-1023
SOURCE: Traders News Source LLC
[ad_2]
Source link